Yıl: 2023 Cilt: 53 Sayı: 1 Sayfa Aralığı: 45 - 50 Metin Dili: İngilizce DOI: 10.26650/IstanbulJPharm.2023.1156339 İndeks Tarihi: 30-05-2023

Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria

Öz:
Background and Aims: Gram-negative bacteria are important pathogens that can cause community- and hospital-acquired infections as well as opportunistic infections, with antimicrobial resistance in Gram-negative bacteria becoming a growing crisis in clinical medicine. Biofilm formation is one of the mechanisms of bacterial resistance, which makes bacteria less susceptible to antimicrobial agents and unable to be killed by host immune mechanisms. Therefore, this study investigates the antimicrobial resistances and biofilm-forming abilities of a total of 98 Gram-negative strains isolated from various clinical specimens. Methods: A disc diffusion assay was performed to detect the susceptibility profiles of 98 Gram-negative strains. The biofilmforming abilities of strains were also determined using the Crystal Violet assay. Results: Concerning the disc diffusion assay, most of the isolates were found to be resistant to carbapenems, with more than 90% of Acinetobacter baumannii, Klebsiella pneumoniae and Escherichia coli isolates being found resistant to ceftazidime and piperacillin. Most of the Pseudomonas aeruginosa isolates (75%) were found to be resistant to imipenem and aztreonam. All isolates had the ability to form biofilms. Overall, 56% of isolates were strong formers, and 29% were moderate biofilm formers. Strong biofilm formation was observed in most strains except for K. pneumoniae. Conclusion: The surveillance of susceptibility profiles and biofilm formation is important for determining their variable susceptibility patterns and aiding in the appropriate management of infections caused by these organisms.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • • Avcıoğlu, F. & Behçet, M. (2020). Üriner sistem enfeksiyonu etkeni Escherichia coli izolatlarının çeşitli antibiyotiklere direnç oranlarının değerlendirilmesi. Türk Mikrobiyoloji Cemiyeti Dergisi, 50(3), 172-7.
  • • Bader, M. S., Loeb, M., Leto, D., & Brooks, A. A. (2020). Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgraduate Medicine, 132(3), 234–250. https://doi.org/10.1080/00325481.2019.1680052
  • • Breijyeh, Z., Jubeh, B., & Karaman, R. (2020). Resistance of gramnegative bacteria to current antibacterial agents and approaches to resolve it. Molecules, 25(6), 1340.
  • • Candan, E. D., & Aksöz, N. (2015). Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. Acta Biochimica Polonica, 62(4), 867–874. https://doi.org/10.18388/ abp.2015_1148
  • • Center for Disease Control and Prevention (CDC). Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019.
  • • Cepas, V., López, Y., Muñoz, E., Rolo, D., Ardanuy, C., Martí, S., Xercavins, M., Horcajada, J. P., Bosch, J., & Soto, S. M. (2019). Relationship between biofilm formation and antimicrobial resistance in Gram-negative bacteria. Microbial Drug Resistance (Larchmont, N.Y.), 25(1), 72–79. https://doi.org/10.1089/mdr.2018.0027
  • • Chung, H.S., Hong, SG., Lee, Y., Kim, M., Yong, D. Jeong, SH., Lee, K. & Chong, Y. (2012). Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from a Korean tertiary care hospital. Yonsei Medical Journal 53(2), 439-41. doi: 10.3349/ymj.2012.53.2.439. PMID: 22318836; PMCID: PMC3282950.
  • • Clinical and Laboratory Standards Institute (CLSI) (2021) Performance Standards for Antimicrobial. Document M100-Ed.31., Wayne, PA: CLSI.
  • • Del Pozo J. L. (2018). Biofilm-related disease. Expert Review of Anti- Infective Therapy, 16(1), 51–65. https://doi.org/10.1080/14787210 .2018.1417036
  • • Dosler, S. & Karaaslan E. (2014). Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides. Peptides, 62, 32-37.
  • • Dumaru, R., Baral, R., & Shrestha, L. B. (2019). Study of biofilm formation and antibiotic resistance pattern of gram-negative Bacilli among the clinical isolates at BPKIHS, Dharan. BMC Research Notes, 12(1), 38. https://doi.org/10.1186/s13104-019-4084-8
  • • Eichenberger, E. M., & Thaden, J. T. (2019). Epidemiology and mechanisms of resistance of extensively drug resistant Gramnegative bacteria. Antibiotics, 8(2), 37.
  • • El-Gamal, M. I., Brahim, I., Hisham, N., Aladdin, R., Mohammed, H., & Bahaaeldin, A. (2017). Recent updates of carbapenem antibiotics. European Journal of Medicinal Chemistry, 131, 185–195. https:// doi.org/10.1016/j.ejmech.2017.03.022
  • • Hammoudi Halat, D., & Ayoub Moubareck, C. (2020). The current burden of carbapenemases: Review of significant properties and dissemination among Gram-negative bacteria. Antibiotics, 9(4), 186.
  • • İnce, G., Mirza, H. C., Üsküdar Güçlü, A., Gümüş, H., Erol, Ç., & Başustaoğlu, A. (2021). Comparison of in vitro activities of plazomicin and other aminoglycosides against clinical isolates of Klebsiella pneumoniae and Escherichia coli. The Journal of Antimicrobial Chemotherapy, 76(12), 3192–3196. https://doi.org/10.1093/jac/ dkab331
  • • Jamal, M., Ahmad, W., Andleeb, S., Jalil, F., Imran, M., Nawaz, M. A., Hussain, T., Ali, M., Rafiq, M., & Kamil, M. A. (2018). Bacterial biofilm and associated infections. Journal of the Chinese Medical Association: JCMA, 81(1), 7–11. https://doi.org/10.1016/j.jcma.2017.07.012
  • • Jia, X., Ma, W., He, J., Tian, X., Liu, H., Zou, H., & Cheng, S. (2020). Heteroresistance to cefepime in Pseudomonas aeruginosa bacteraemia. International Journal of Antimicrobial Agents, 55(3), 105832. https://doi.org/10.1016/j.ijantimicag.2019.10.013
  • • Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., & Monnet, D. L. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection, 18(3), 268- 281.
  • • Malone, L., & Kwon, D. H. (2013). Carbapenem-associated multidrug- resistant Acinetobacter baumannii are sensitised by aztreonam in combination with polyamines. International journal of Antimicrobial Agents, 41(1), 70–74. https://doi.org/10.1016/j. ijantimicag.2012.08.009
  • • Mirza, H. C., Sancak, B., (2020). Comparison of antimicrobial susceptibilities of Escherichia coli isolated from urinary cultures of different patient groups: A university hospital experience. Klimik Dergisi, 33(3), 270-6.
  • • Mojica, M. F., Humphries, R., Lipuma, J. J., Mathers, A. J., Rao, G. G., Shelburne, S. A., Fouts, D. E., Van Duin, D., & Bonomo, R. A. (2022). Clinical challenges treating Stenotrophomonas maltophilia infections: an update. JAC-Antimicrobial Resistance, 4(3), dlac040. https://doi.org/10.1093/jacamr/dlac040
  • • Namaei, M. H., Yousefi, M., Askari, P., Roshanravan, B., Hashemi, A., & Rezaei, Y. (2021). High prevalence of multidrug-resistant non-fermentative Gram-negative bacilli harboring blaIMP-1 and blaVIM-1 metallo-beta-lactamase genes in Birjand, south-east Iran. Iranian Journal of Microbiology, 13(4), 470–479. https://doi. org/10.18502/ijm.v13i4.6971
  • • Nirwati, H., Sinanjung, K., Fahrunissa, F., Wijaya, F., Napitupulu, S., Hati, V. P., Hakim, M. S., Meliala, A., Aman A. T., & Nuryastuti, T. (2019). Biofilm formation and antibiotic resistance of Klebsiella pneumoniae isolated from clinical samples in a tertiary care hospital, Klaten, Indonesia. BMC Proceedings, 13(11), 1-8. https://doi. org/10.1186/s12919-019-0176-7
  • • Pang, Z., Raudonis, R., Glick, B. R., Lin, T. J., & Cheng, Z. (2019). Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnology Advances, 37(1), 177–192. https://doi.org/10.1016/j.biotechadv.2018.11.013
  • • Peeters, E., Nelis, H. J. & Coenye. T., (2008). Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. Journal of Microbiology Methods, 72(2), 157-165. doi:10.1016/j.mimet.2007.11.010
  • • Perdikouri, E. I. A., Arvaniti, K., Lathyris, D., Apostolidou Kiouti, F., Siskou, E., Haidich, A. B., & Papandreou, C. (2019). Infections due to multidrug-resistant bacteria in oncological patients: insights from a five-year epidemiological and clinical analysis. Microorganisms, 7(9), 277.
  • • Peters, L., Olson, L., Khu, D. T., Linnros, S., Le, N. K., Hanberger, H. & Larsson, M. (2019). Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: a cohort study among neonatal intensive care patients with hospital-acquired infections caused by Gram-negative bacteria in Vietnam. PloS one, 14(5), e0215666.
  • • Rice, L. B. (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. The Journal of Infectious Diseases, 197(8), 1079-1081.
  • • Thaden, J. T., Li, Y., Ruffin, F., Maskarinec, S. A., Hill-Rorie, J. M., Wanda, L. C., & Fowler Jr, V. G. (2017). Increased costs associated with bloodstream infections caused by multidrug-resistant gram-negative bacteria are due primarily to patients with hospital-acquired infections. Antimicrobial Agents and Chemotherapy, 61(3), e01709- 16.
  • • Vivas, R., Barbosa, A. A. T., Dolabela, S. S., & Jain, S. (2019). Multidrug- resistant bacteria and alternative methods to control them: an overview. Microbial Drug Resistance, 25(6), 890-908.
  • • Wang, G., Zhao, G., Chao, X., Xie, L., & Wang, H. (2020). The characteristic of virulence, biofilm and antibiotic resistance of Klebsiella pneumoniae. International Journal of Environmental Research and Public Health, 17(17), 6278.
  • • World Health Organization (WHO) https://www.who.int/newsroom/ fact-sheets/detail/antimicrobial-resistance
  • • Yadav, S.K., Bhujel, R. & Mishra, S.K. (2020). Emergence of multidrug- resistant non-fermentative gram negative bacterial infection in hospitalized patients in a tertiary care center of Nepal. BMC Res Notes, 13, 319. https://doi.org/10.1186/s13104-020-05163-6
APA OYARDI O, HACIOGLU M, Yılmaz F, İNAN U, Birteksöz Tan A (2023). Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria. , 45 - 50. 10.26650/IstanbulJPharm.2023.1156339
Chicago OYARDI OZLEM,HACIOGLU MAYRAM,Yılmaz Fatıma nur,İNAN Urdoğan Neşe,Birteksöz Tan Ayşe Seher Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria. (2023): 45 - 50. 10.26650/IstanbulJPharm.2023.1156339
MLA OYARDI OZLEM,HACIOGLU MAYRAM,Yılmaz Fatıma nur,İNAN Urdoğan Neşe,Birteksöz Tan Ayşe Seher Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria. , 2023, ss.45 - 50. 10.26650/IstanbulJPharm.2023.1156339
AMA OYARDI O,HACIOGLU M,Yılmaz F,İNAN U,Birteksöz Tan A Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria. . 2023; 45 - 50. 10.26650/IstanbulJPharm.2023.1156339
Vancouver OYARDI O,HACIOGLU M,Yılmaz F,İNAN U,Birteksöz Tan A Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria. . 2023; 45 - 50. 10.26650/IstanbulJPharm.2023.1156339
IEEE OYARDI O,HACIOGLU M,Yılmaz F,İNAN U,Birteksöz Tan A "Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria." , ss.45 - 50, 2023. 10.26650/IstanbulJPharm.2023.1156339
ISNAD OYARDI, OZLEM vd. "Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria". (2023), 45-50. https://doi.org/10.26650/IstanbulJPharm.2023.1156339
APA OYARDI O, HACIOGLU M, Yılmaz F, İNAN U, Birteksöz Tan A (2023). Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria. Istanbul Journal of Pharmacy, 53(1), 45 - 50. 10.26650/IstanbulJPharm.2023.1156339
Chicago OYARDI OZLEM,HACIOGLU MAYRAM,Yılmaz Fatıma nur,İNAN Urdoğan Neşe,Birteksöz Tan Ayşe Seher Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria. Istanbul Journal of Pharmacy 53, no.1 (2023): 45 - 50. 10.26650/IstanbulJPharm.2023.1156339
MLA OYARDI OZLEM,HACIOGLU MAYRAM,Yılmaz Fatıma nur,İNAN Urdoğan Neşe,Birteksöz Tan Ayşe Seher Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria. Istanbul Journal of Pharmacy, vol.53, no.1, 2023, ss.45 - 50. 10.26650/IstanbulJPharm.2023.1156339
AMA OYARDI O,HACIOGLU M,Yılmaz F,İNAN U,Birteksöz Tan A Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria. Istanbul Journal of Pharmacy. 2023; 53(1): 45 - 50. 10.26650/IstanbulJPharm.2023.1156339
Vancouver OYARDI O,HACIOGLU M,Yılmaz F,İNAN U,Birteksöz Tan A Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria. Istanbul Journal of Pharmacy. 2023; 53(1): 45 - 50. 10.26650/IstanbulJPharm.2023.1156339
IEEE OYARDI O,HACIOGLU M,Yılmaz F,İNAN U,Birteksöz Tan A "Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria." Istanbul Journal of Pharmacy, 53, ss.45 - 50, 2023. 10.26650/IstanbulJPharm.2023.1156339
ISNAD OYARDI, OZLEM vd. "Antibiotic susceptibility and biofilm formation of multi-drug resistant Gram-negative bacteria". Istanbul Journal of Pharmacy 53/1 (2023), 45-50. https://doi.org/10.26650/IstanbulJPharm.2023.1156339